SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-026737
Filing Date
2021-11-15
Accepted
2021-11-15 16:23:14
Documents
27
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbli20211112_8k.htm   iXBRL 8-K 32399
2 EXHIBIT 99.1 ex_308233.htm EX-99.1 172797
3 EXHIBIT 99.2 ex_307471.htm EX-99.2 7131
8 a01.jpg GRAPHIC 192475
9 a02.jpg GRAPHIC 228856
10 a03.jpg GRAPHIC 200634
11 a04.jpg GRAPHIC 161836
12 a05.jpg GRAPHIC 71275
13 a06.jpg GRAPHIC 206391
14 a07.jpg GRAPHIC 199178
15 a08.jpg GRAPHIC 68939
16 a09.jpg GRAPHIC 121077
17 a10.jpg GRAPHIC 114513
18 a11.jpg GRAPHIC 98678
19 logo.jpg GRAPHIC 6215
  Complete submission text file 0001437749-21-026737.txt   2663542

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA stab-20211115.xsd EX-101.SCH 3594
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stab-20211115_def.xml EX-101.DEF 11425
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE stab-20211115_lab.xml EX-101.LAB 15311
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stab-20211115_pre.xml EX-101.PRE 11585
20 EXTRACTED XBRL INSTANCE DOCUMENT cbli20211112_8k_htm.xml XML 2569
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 211411066
SIC: 2834 Pharmaceutical Preparations